2009
DOI: 10.1016/j.tem.2009.01.002
|View full text |Cite
|
Sign up to set email alerts
|

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
234
1
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 243 publications
(240 citation statements)
references
References 105 publications
4
234
1
1
Order By: Relevance
“…The reduction in serum IGF-1 could indicate amelioration of an IGF-1 signaling defect in skeletal muscle (10,26). Alternatively, the increase in IGFBP-1 could stimulate IGF-1 action at the cellular level, despite lower serum IGF-1 (27,28). Higher serum IGFBP-1 could reflect improved insulin sensitivity (28), which has been shown with the treatment of acidosis and would reduce muscle proteolysis (29,30).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…The reduction in serum IGF-1 could indicate amelioration of an IGF-1 signaling defect in skeletal muscle (10,26). Alternatively, the increase in IGFBP-1 could stimulate IGF-1 action at the cellular level, despite lower serum IGF-1 (27,28). Higher serum IGFBP-1 could reflect improved insulin sensitivity (28), which has been shown with the treatment of acidosis and would reduce muscle proteolysis (29,30).…”
Section: Discussionmentioning
confidence: 98%
“…Alternatively, the increase in IGFBP-1 could stimulate IGF-1 action at the cellular level, despite lower serum IGF-1 (27,28). Higher serum IGFBP-1 could reflect improved insulin sensitivity (28), which has been shown with the treatment of acidosis and would reduce muscle proteolysis (29,30). It should be noted that the decrease in serum IGF-1 in our study contrasts with previous findings of an acidosis-induced impairment of growth hormone (GH)-stimulated IGF-1 expression (31).…”
Section: Discussionmentioning
confidence: 99%
“…Normal nerve (Figure 1d, upper right panel) and traumatic neuroma (Figure 1d, middle right panel) expressed IGFBP-1 weakly compared with schwannoma. As IGFBP-2 acts via the same integrins as IGFBP-1 (Perks et al, 2007), displaying some similarities in signalling (Wheatcroft and Kearney, 2009), we tested whether Schwann and schwannoma cells release IGFBP-2. We demonstrated that both cell types release IGFBP-2 equally (Figure 1e).…”
Section: Igfbp-1 Is Upregulated and Released Only From Schwannoma Cellsmentioning
confidence: 99%
“…In this work, evidence is provided for the coupling of pleiotropic functions of IGFBP‐2 being mediated by the RGD‐motif, which is primarily considered to be IGF‐independent (Wheatcroft & Kearney, 2009). However, coupling of reproductive development and lifespan has been clearly demonstrated in Caenorhabditis elegans (Dillin et al ., 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Also, in breast cancer, IGFBP‐2 exerts malignant potential, and again, this depends on the RGD‐motif but involves regulation of estrogen receptors as demonstrated by the Perks laboratory (Foulstone et al ., 2013). In addition, the RGD‐domain has been discussed in a context with metabolic functions of IGFBP‐2 (Wheatcroft & Kearney, 2009). In fact, by direct comparison of D‐ and E‐mice, we were able to demonstrate that the RGD‐motif present in IGFBP‐2 is involved in the regulation of GLUT4 trafficking and glucose clearance after oral glucose administration (Reyer et al ., 2015).…”
Section: Introductionmentioning
confidence: 99%